Roth Mkm Reaffirms Buy Rating for TriSalus Life Sciences (NASDAQ:TLSI)
Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...
Nasdaq1mon
Roth MKM ‘cautiously optimistic’ on Digi International in FY26
Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...
Roth calls ‘Narnia’ deal with Netflix ‘significant’ for Imax
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
Roth MKM Keeps Their Buy Rating on American Superconductor (AMSC)
Roth MKM analyst Justin Clare reiterated a Buy rating on American Superconductor (AMSC – Research Report) today and set a price target of ...
Nasdaq1mon
Roth MKM Initiates Coverage of U.S. Gold (LSE:0LHW) with Buy Recommendation
Fintel reports that on December 18, 2024, Roth MKM initiated coverage of U.S. Gold (LSE:0LHW) with a Buy recommendation. As of December 3, 2024, the average one-year price target for U.S. Gold is ...
Yahoo Finance1mon
CervoMed price target lowered to $4 from $45 at Roth MKM
https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 ...
Roth MKM Remains a Hold on AMMO (POWW)
Roth MKM analyst Matt Koranda maintained a Hold rating on AMMO (POWW – Research Report) today and set a price target of $1.75. The company’s ...
Innventure (NASDAQ:INV) Upgraded at Roth Capital
Roth Capital upgraded shares of Innventure (NASDAQ:INV – Free Report) to a strong-buy rating in a report issued on Thursday,Zacks.com reports. Separately, Roth Mkm assumed coverage on Innventure in a ...